X-ray crystal structure of the opioid ligand naltrexonazine
- 1 August 1987
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 30 (8), 1489-1494
- https://doi.org/10.1021/jm00391a035
Abstract
The anti-anti isomer of naltrexonazine (1) was synthesized, and its configuration was confirmed by X-ray crystallography. The syn-anti isomer is readily converted to 1 under acidic conditions. The apparent equal receptor binding of 1 and syn-anti isomer indicates that isomerization of the azine moiety may take place under the conditions of biological evaluation. Two possible explanations for wash-resistant binding of 1 to opioid receptors are presented. The first possibility involves a noncovalent interaction of the ligand with the opioid receptor, and the second considers covalent binding by a receptor-based sulfhydryl group.This publication has 7 references indexed in Scilit:
- Crystal structures of .alpha.- and .beta.-funaltrexamine: conformational requirement of the fumaramate moiety in the irreversible blockage of .mu. opioid receptorsJournal of Medicinal Chemistry, 1986
- IRREVERSIBLE OPIATE AGONISTS AND ANTAGONISTS .3. PHENYLHYDRAZONE DERIVATIVES OF NALOXONE AND OXYMORPHONE1985
- Opioid receptor interactions and conformations of the 6.alpha. and 6.beta. epimers of oxymorphamine. Solid-state conformation of 6.alpha.-oxymorphamineJournal of Medicinal Chemistry, 1985
- Receptor binding and biological activity of bivalent enkephalinsBiochemical Pharmacology, 1985
- BIOCHEMICAL-CHARACTERIZATION OF HIGH-AFFINITY H-3 OPIOID BINDING - FURTHER EVIDENCE FOR MU1-SITES1984
- Increased biological activity of dimers of oxymorphone and enkephalin: Possible role of receptor crosslinkingBiochemical and Biophysical Research Communications, 1982
- Classification of multiple morphine and enkephalin binding sites in the central nervous system.Proceedings of the National Academy of Sciences, 1981